Paraplatin and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Paraplatin (carboplatin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Taxol, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Heart attack when taking Paraplatin. It is created by eHealthMe based on reports of 12,385 people who have side effects when taking Paraplatin from the FDA, and is updated regularly.

What is Paraplatin?

Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.

What is Heart attack?

Heart attack is found to be associated with 2,485 drugs and 3,296 conditions by eHealthMe. Check the latest studies of Heart attack.



On Jul, 13, 2026

12,385 people reported to have side effects when taking Paraplatin.
Among them, 51 people (0.41%) have Heart attack.

Could Paraplatin cause Heart attack?

Among these 51 people:

How long have people been on Paraplatin when they have Heart attack? *

  • < 1 month: 57.14 %
  • 1 - 6 months: 42.86 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Heart attack when taking Paraplatin? *

  • female: 55.32 %
  • male: 44.68 %

What is the age of people who have Heart attack when taking Paraplatin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4 %
  • 30-39: 0.0 %
  • 40-49: 12 %
  • 50-59: 12 %
  • 60+: 72 %

What are other drugs people take besides Paraplatin? *

  1. Taxol: 26 people, 50.98%
  2. Taxotere: 5 people, 9.80%
  3. Etoposide: 4 people, 7.84%
  4. Zofran: 4 people, 7.84%
  5. Decadron: 3 people, 5.88%
  6. Avastin: 3 people, 5.88%
  7. Paclitaxel: 2 people, 3.92%
  8. Cisplatin: 2 people, 3.92%
  9. Solu-Medrol: 2 people, 3.92%
  10. Dexamethasone: 2 people, 3.92%

What are other side effects people have besides Heart attack? *

  1. Chest Pain: 6 people, 11.76%
  2. Hypotension (abnormally low blood pressure): 6 people, 11.76%
  3. Blood Creatine Phosphokinase Mb Increased: 3 people, 5.88%
  4. Nausea (feeling of having an urge to vomit): 3 people, 5.88%
  5. Fatigue (feeling of tiredness): 3 people, 5.88%
  6. Fainting (loss of consciousness and postural tone): 3 people, 5.88%
  7. Ejection Fraction Abnormal (abnormality in percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat): 3 people, 5.88%
  8. Depressed Level Of Consciousness: 3 people, 5.88%
  9. Joint Pain: 3 people, 5.88%
  10. Thrombocytopenia (decrease of platelets in blood): 3 people, 5.88%

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 6 people, 11.76%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.96%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 1.96%
  4. Ovarian Cancer (cancer of ovary): 1 person, 1.96%
  5. Osteoporosis (bones weak and more likely to break): 1 person, 1.96%
  6. Metastases To Bone (cancer spreads to bone): 1 person, 1.96%
  7. Breast Cancer Metastatic: 1 person, 1.96%
  8. Bone Loss: 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Paraplatin and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paraplatin:

Heart attack treatments and more:

How severe was Heart attack and when was it recovered:

Expand to all the drugs that have ingredients of carboplatin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paraplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Browse all the conditions that are associated with Heart attack:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Paraplatin) and Paraplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: